EndoChoice Holdings Top Insiders
EndoChoice Holdings employs about 501 people. The company is managed by 20 executives with a total tenure of roughly 208 years, averaging almost 10.0 years of service per executive, having 25.05 employees per reported executive. Assessment of EndoChoice Holdings' management performance can provide insight into the firm performance.
Simon Tam CEO President CEO, Director |
Mark Gilreath CEO Founder, CEO and President and Director |
EndoChoice |
EndoChoice Holdings Management Team Effectiveness
The company has Return on Asset (ROA) of (0.473) % which means that for every 100 dollars spent on asset, it generated a loss of $0.473. This is way below average. EndoChoice Holdings' management efficiency ratios could be used to measure how well EndoChoice Holdings manages its routine affairs as well as how well it operates its assets and liabilities.EndoChoice Holdings Notable Stakeholders
An EndoChoice Holdings stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EndoChoice Holdings often face trade-offs trying to please all of them. EndoChoice Holdings' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EndoChoice Holdings' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Simon Tam | President CEO, Director | Profile | |
Mark Gilreath | Founder, CEO and President and Director | Profile | |
Scott Huennekens | Chairman of the Board | Profile | |
John Barr | Chairman of the Board, Interim CEO | Profile | |
Simon MA | CFO | Profile | |
David Gill | CFO | Profile | |
Kevin Rubey | COO | Profile | |
David Kaufman | Director | Profile | |
David Mowry | Director | Profile | |
Rurik Vandevenne | Director | Profile | |
John Smyth | Director | Profile | |
James Balkcom | Director | Profile | |
Scott Davis | Director | Profile | |
Uri Geiger | Director | Profile | |
Scott Carter | Director | Profile | |
Craig Walker | Director | Profile | |
William Enquist | Director | Profile | |
Michael Ballanger | Director | Profile | |
Eric Schjelderup | Director | Profile | |
Douglas Ladd | Chief Marketing Officer | Profile |
EndoChoice Holdings Workforce Analysis
Traditionally, organizations such as EndoChoice Holdings use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EndoChoice Holdings within its industry.EndoChoice Holdings Manpower Efficiency
Return on EndoChoice Holdings Manpower
Revenue Per Employee | 144.3K | |
Revenue Per Executive | 3.6M | |
Net Loss Per Employee | 118.5K | |
Net Loss Per Executive | 3M | |
Working Capital Per Employee | 159.3K | |
Working Capital Per Executive | 4M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in EndoChoice Stock
If you are still planning to invest in EndoChoice Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EndoChoice Holdings' history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |